These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3926140)

  • 1. Visual evoked potential and contrast sensitivity function in diabetic retinopathy.
    Collier A; Mitchell JD; Clarke BF
    Br Med J (Clin Res Ed); 1985 Jul; 291(6490):248. PubMed ID: 3926140
    [No Abstract]   [Full Text] [Related]  

  • 2. [The visual evoked potentials in diabetic retinopathy].
    Costache D; Damian C; Iancău M
    Oftalmologia; 2004; 48(1):53-7. PubMed ID: 15279420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of visual pathways using visual evoked potential in patients with diabetic retinopathy.
    Corduneanu A; Chişca V; Ciobanu N; Groppa S
    Rom J Ophthalmol; 2019; 63(4):367-371. PubMed ID: 31915735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurovisual abnormalities preceding the retinopathy in patients with long-term type 1 diabetes mellitus.
    Lopes de Faria JM; Katsumi O; Cagliero E; Nathan D; Hirose T
    Graefes Arch Clin Exp Ophthalmol; 2001 Sep; 239(9):643-8. PubMed ID: 11688662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual evoked potentials in diabetic children and adolescents.
    Cirillo D; Gonfiantini E; De Grandis D; Bongiovanni L; Robert JJ; Pinelli L
    Diabetes Care; 1984; 7(3):273-5. PubMed ID: 6734398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired saccadic eye movement in diabetic patients: the relationship with visual pathways function.
    Alessandrini M; Paris V; Bruno E; Giacomini PG
    Doc Ophthalmol; 1999; 99(1):11-20. PubMed ID: 10947006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvment of the visual evoked potentials in type I insulin-dependent diabetes.
    Ponte F; Giuffrè G; Anastasi M; Lauricella M
    Metab Pediatr Syst Ophthalmol (1985); 1986; 9(2-4):77-80. PubMed ID: 3452012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual evoked responses in diabetes.
    Millingen KS; Yeo PT; Kamaldeen S
    Clin Exp Neurol; 1987; 24():153-8. PubMed ID: 3268341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual evoked potential can be used to detect a prediabetic form of diabetic retinopathy in patients with diabetes mellitus type I.
    Karlica D; Galetović D; Ivanisević M; Skrabić V; Znaor L; Jurisić D
    Coll Antropol; 2010 Jun; 34(2):525-9. PubMed ID: 20698126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic value of electrophysiologic studies in diabetics in our experience].
    Palacz O; Czepita D; Lubiński W; Wieliczko W; Czekalski S
    Klin Oczna; 1989; 91(7-9):191-3. PubMed ID: 2638441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inner retinal visual dysfunction is a sensitive marker of non-proliferative diabetic retinopathy.
    Jackson GR; Scott IU; Quillen DA; Walter LE; Gardner TW
    Br J Ophthalmol; 2012 May; 96(5):699-703. PubMed ID: 22174096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Visual evoked potentials in diabetics].
    Bártek L; Gat'ková A; Rybka J; Kalita Z; Smecka Z
    Cesk Oftalmol; 1989 May; 45(3):192-6. PubMed ID: 2743440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saccadic eye movement and visual pathways function in diabetic patients.
    Alessandrini M; Bruno E; Parisi V; Uccioli L; Giacomini PG
    An Otorrinolaringol Ibero Am; 2001; 28(3):269-80. PubMed ID: 11455884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient-like function and associated retinal capillary anomalies. Analysis of a patient with early retinopathy secondary to juvenile-onset diabetes mellitus.
    Temme LA; Enoch JM; Fitzgerald CR; Merimee TJ
    Invest Ophthalmol Vis Sci; 1980 Sep; 19(9):991-1008. PubMed ID: 7410007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic value of the oscillatory potentials of the ERG and fluorescein angiography in diabetic proliferative retinopathy.
    Algvere P; Gjötterberg M
    Ophthalmologica; 1974; 168(2):97-108. PubMed ID: 4842096
    [No Abstract]   [Full Text] [Related]  

  • 16. Optic pathway conduction in insulin-dependent diabetics.
    Ponte F; Anastasi M; Lauricella M; Bompiani GD
    Doc Ophthalmol; 1986 Nov; 63(4):313-9. PubMed ID: 3803162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The picture of visual evoked potentials in type 1 diabetes mellitus].
    Szabela DA; Loba J; Pałenga-Pydyn D; Tybor K; Ruxer J; Split W
    Klin Oczna; 2005; 107(7-9):492-7. PubMed ID: 16417005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in mild to moderate nonproliferative diabetic retinopathy: a randomized proof-of-concept clinical trial.
    Scott IU; Jackson GR; Quillen DA; Klein R; Liao J; Gardner TW
    JAMA Ophthalmol; 2014 Sep; 132(9):1137-42. PubMed ID: 24969516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hue discrimination and S cone pathway sensitivity in early diabetic retinopathy.
    Greenstein V; Sarter B; Hood D; Noble K; Carr R
    Invest Ophthalmol Vis Sci; 1990 Jun; 31(6):1008-14. PubMed ID: 2354907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blue-yellow deficits in diabetes.
    Maddess T
    Clin Exp Ophthalmol; 2004 Oct; 32(5):556. PubMed ID: 15498079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.